ZEPZELCA Powder for concentrate for solution for infusion Ref.[116643] Active ingredients: Lurbinectedin

Source: European Medicines Agency (EU)  Revision Year: 2026  Publisher: Pharma Mar, S.A., Avda. de los Reyes 1, Polígono Industrial La Mina, 28770 Colmenar Viejo (Madrid), Spain, Tel: +34 91 846 60 00, Fax: +34 91 846 60 01

Product name and form

ZEPZELCA 2 mg powder for concentrate for solution for infusion.

ZEPZELCA 4 mg powder for concentrate for solution for infusion.

Pharmaceutical Form

Powder for concentrate for solution for infusion (powder for concentrate).

White to off-white powder.

Qualitative and quantitative composition

ZEPZELCA 2 mg powder for concentrate for solution for infusion: Each vial of powder contains 2 mg of lurbinectedin.

ZEPZELCA 4 mg powder for concentrate for solution for infusion: Each vial of powder contains 4 mg of lurbinectedin.

One mL of reconstituted solution contains 0.5 mg of lurbinectedin.

For the full list of excipients, see section 6.1.

Active Ingredient

Lurbinectedin inhibits the oncogenic transcription process through (i) its binding to CG-rich sequences of DNA, located within promoters of protein-coding genes; (ii) the eviction of oncogenic transcription factors from their binding sites; and (iii) the stalling of elongating RNA polymerase II and its specific degradation by the ubiquitin/proteasome machinery with all these processes leading to subsequent cell cycle arrest and tumour cell apoptosis.

List of Excipients

Sucrose
Lactic acid
Sodium hydroxide (for pH-adjustment)

Pack sizes and marketing

ZEPZELCA 2 mg powder for concentrate for solution for infusion:

20 mL vial (clear type 1 glass) with a stopper (butyl rubber) and white coloured overseal (aluminium), containing 2 mg lurbinectedin.

Pack size of 1 vial.

ZEPZELCA 4 mg powder for concentrate for solution for infusion:

30 mL vial (clear type 1 glass) with a stopper (butyl rubber) and blue coloured overseal (aluminium), containing 4 mg lurbinectedin.

Pack size of 1 vial.

Marketing authorization holder

Pharma Mar, S.A., Avda. de los Reyes 1, Polígono Industrial La Mina, 28770 Colmenar Viejo (Madrid), Spain, Tel: +34 91 846 60 00, Fax: +34 91 846 60 01

Marketing authorization dates and numbers

EU/1/26/2032/001
EU/1/26/2032/002

Drugs

Drug Countries
ZEPZELCA Ecuador, Israel, Lithuania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.